Next Article in Journal
Computer Extracted Features from Initial H&E Tissue Biopsies Predict Disease Progression for Prostate Cancer Patients on Active Surveillance
Next Article in Special Issue
Experimental Assessment of Color Deconvolution and Color Normalization for Automated Classification of Histology Images Stained with Hematoxylin and Eosin
Previous Article in Journal
Glioblastoma Tissue Slice Tandem-Cultures for Quantitative Evaluation of Inhibitory Effects on Invasion and Growth
Previous Article in Special Issue
Computer-Aided Diagnosis in Multiparametric MRI of the Prostate: An Open-Access Online Tool for Lesion Classification with High Accuracy
Open AccessArticle

Machine Learning Model to Predict Pseudoprogression Versus Progression in Glioblastoma Using MRI: A Multi-Institutional Study (KROG 18-07)

1
Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam 13620, Korea
2
Artificial Intelligence Research and Development Laboratory, SELVAS AI Incorporation, Seoul 08594, Korea
3
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea
4
Department of Radiation Oncology, Seoul National University Hospital, Seoul 03080, Korea
5
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea
6
Department of Radiation Oncology, School of Medicine, Kyungpook National University, Daegu 41944, Korea
7
Department of Radiation Oncology, Pusan National University Hospital, Busan 49241, Korea
8
The Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang 10408, Korea
9
Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu 42601, Korea
10
Department of Radiology, Seoul National University Bundang Hospital, Seongnam 13620, Korea
11
Department of Radiology, Seoul National University Hospital, Seoul 03080, Korea
12
Department of Radiation Oncology, Cancer Research Institute and BK21 Four—Smart Healthcare, College of Medicine, Seoul National University, Seoul 03080, Korea
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(9), 2706; https://doi.org/10.3390/cancers12092706
Received: 6 July 2020 / Revised: 16 September 2020 / Accepted: 17 September 2020 / Published: 21 September 2020
(This article belongs to the Special Issue Machine Learning Techniques in Cancer)
Even after the introduction of a standard regimen consisting of concurrent chemoradiotherapy and adjuvant temozolomide, patients with glioblastoma multiforme mostly experience disease progression. Clinicians often encounter a situation where they need to distinguish progressive disease from pseudoprogression after treatment. We tried to investigate the feasibility of machine learning algorithm to distinguish pseudoprogression from progressive disease. In multi-institutional dataset, the developed machine learning model showed an acceptable performance. This algorithm involving MRI data and clinical features could help making decision during patients’ disease course. For the practical use, we calibrated the machine learning model to offer the probability of pseudoprogression to clinicians, then we constructed the web-based user interface to access the model.
Some patients with glioblastoma show a worsening presentation in imaging after concurrent chemoradiation, even when they receive gross total resection. Previously, we showed the feasibility of a machine learning model to predict pseudoprogression (PsPD) versus progressive disease (PD) in glioblastoma patients. The previous model was based on the dataset from two institutions (termed as the Seoul National University Hospital (SNUH) dataset, N = 78). To test this model in a larger dataset, we collected cases from multiple institutions that raised the problem of PsPD vs. PD diagnosis in clinics (Korean Radiation Oncology Group (KROG) dataset, N = 104). The dataset was composed of brain MR images and clinical information. We tested the previous model in the KROG dataset; however, that model showed limited performance. After hyperparameter optimization, we developed a deep learning model based on the whole dataset (N = 182). The 10-fold cross validation revealed that the micro-average area under the precision-recall curve (AUPRC) was 0.86. The calibration model was constructed to estimate the interpretable probability directly from the model output. After calibration, the final model offers clinical probability in a web-user interface. View Full-Text
Keywords: machine learning; glioblastoma; radiotherapy; pseudoprogression machine learning; glioblastoma; radiotherapy; pseudoprogression
Show Figures

Figure 1

MDPI and ACS Style

Jang, B.-S.; Park, A.J.; Jeon, S.H.; Kim, I.H.; Lim, D.H.; Park, S.-H.; Lee, J.H.; Chang, J.H.; Cho, K.H.; Kim, J.H.; Sunwoo, L.; Choi, S.H.; Kim, I.A. Machine Learning Model to Predict Pseudoprogression Versus Progression in Glioblastoma Using MRI: A Multi-Institutional Study (KROG 18-07). Cancers 2020, 12, 2706.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop